University College Dublin and Genomics Medicine Ireland (GMI) have announced a collaboration agreement as part of a large-scale population research programme across more than 60 diseases such as multiple sclerosis, diabetes, inflammatory bowel disease and Alzheimer’s.
The collaboration is one of the largest academic and industry collaborations in genomics research to be announced globally and will examine the relationship between genetic variation and human disease in up to 10% of the Irish population.
For verified healthcare professionals
Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.
